Biostealth Technology​

Enhances the biocompatibility and extends the lifespan of medical devices and life support equipment

BCI’s biostealth technology platform is designed to enhance the biocompatibility, durability, and longevity of medical devices by minimizing adverse biological reactions to prosthetic materials.

Utilizing plant-based molecules that form stable bonds with device materials, Protego®, Facta®, Firmo®, and D-Fendor® are built to support long-term biological integration in a broad range of medical applications.

These patented technologies are designed to inhibit the key drivers of device failure, including immune-mediated responses, thrombosis, infection, inflammation, and calcification.
BCI-biocompatibility-innovation-biostealth-technology-6
BCI-biocompatibility-innovation-biostealth-technology-4
BCI-biocompatibility-innovation-biostealth-technology-3
BCI-biocompatibility-innovation-biostealth-technology-2
BCI-biocompatibility-innovation-biostealth-technology-1

Nature-Based Technology

For medical devices made with polymers, metals, and ceramics
For conventionally cross-linked biologic medical devices
For biologic medical devices, replacing current cross-linking methods and fixatives
For dental implants, improving osseointegration and peri-implant mucosal tissue seal

One Platform. Multiple Solutions.

Eliminate the primary causes of medical device failure

By limiting the biological mechanisms that contribute to device degeneration, BCI’s technologies are engineered to preserve device integrity and maintain functionality after implantation.
 
Longer-lasting devices can help reduce complications, limit repeat procedures, and ease the overall burden of care for both patients and healthcare systems.

Key Benefits

Significant patient and healthcare upside plus access to new patient populations.

For virtually all new generation and currently approved medical devices

Longer device lifespan while maintaining intended functionality

Expanded access for patient populations previously ineligible for certain medical devices

Improved patient quality of life and clinical management

Reduced burden on healthcare systems

Rapidly scalable

BCI is committed to developing safe, durable, and responsible solutions for unmet clinical needs.

Our technologies continue to undergo extensive testing and independent evaluation as we move toward regulatory approval.
 
BCI partners with internationally recognized scientists, medical experts, researchers, and leading manufacturers to validate the efficacy and safety of our technologies.